Cambridge Nucleomics
London
About Cambridge Nucleomics
Cambridge Nucleomics offers direct native RNA quantification tech using custom probes and single-molecule detection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2023)
- Website: cambridge-nucleomics.com
Industries & Categories
Biotechnology, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cambridge-nucleomics-229447 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.